FREE Account Opening + No Clearing Fees
Loading...

ANG Lifesciences IPO vs Penta Gold IPO

Comparision between ANG Lifesciences IPO and Penta Gold IPO.

IPO Details

ANG Lifesciences IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Penta Gold IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  ANG Lifesciences IPO Penta Gold IPO
Logo ANG Lifesciences IPO Logo Penta Gold IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Guiness Corporate Advisors Pvt Ltd Inventure Merchant Banker Services Pvt Ltd
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of ANG Lifesciences IPO is up to ₹12.01 Cr whereas the issue size of the Penta Gold IPO is up to ₹13.32 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Penta Gold IPO is ₹37.00 per share.

  ANG Lifesciences IPO Penta Gold IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹80.00 per share ₹37.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 3000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 15,00,800 shares 36,00,000 shares
Issue Size Total (Amount) up to ₹12.01 Cr up to ₹13.32 Cr

IPO Timetable

ANG Lifesciences IPO opens on Aug 29, 2017, while Penta Gold IPO opens on Mar 23, 2018. The closing date of ANG Lifesciences IPO and Penta Gold IPO is Aug 31, 2017, and Mar 27, 2018, respectively.

  ANG Lifesciences IPO Penta Gold IPO
Anchor Bid Date
Issue Open Aug 29, 2017 Mar 23, 2018
Issue Close Aug 31, 2017 Mar 27, 2018
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

ANG Lifesciences IPO P/E ratio is , as compared to Penta Gold IPO P/E ratio of .

  ANG Lifesciences IPO Penta Gold IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 7,660.11 6,381.97 5,878.04 4,822.13 5,068.27
Total Revenue 23,757.84 24,491.76 25,001.70 83,826.41 27,430.69
Profit After Tax 168.53 177.89 158.24 138.38 57.10
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the ANG Lifesciences IPO retail investors (RII) are offered 7,12,000 shares while in Penta Gold IPO retail investors are offered 7,12,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Penta Gold IPO.

  ANG Lifesciences IPO Penta Gold IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,80,000 shares
QIB 0 shares 0 shares
NII 7,12,000 shares 17,10,000 shares
RII 7,12,000 shares 17,10,000 shares
Employee
Others
Total 14,24,000 shares 36,00,000 shares

Bids Received (Subscription)

ANG Lifesciences IPO subscribed in total, whereas Penta Gold IPO subscribed 0.59x.

  ANG Lifesciences IPO Penta Gold IPO
QIB (times)
NII (times) 1.02x
Big NII (times)
Small NII (times)
RII (times) 0.16x
Employee (times)
Other (times)
Total (times) 0.59x

Comments

Add a public comment...